AP NEWS

Global Pharmaceutical Excipients Market Outlook to 2023: A $7.8 Billion Opportunity - ResearchAndMarkets.com

December 20, 2018

DUBLIN--(BUSINESS WIRE)--Dec 20, 2018--The “Global Pharmaceutical Excipients Market - Forecasts From 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering.

The global pharmaceutical excipients market is expected to reach US$7.79 billion by 2023 from US$5.181 billion in 2017 growing at a CAGR of 7.03%.

The market is expected to show a significant growth during the given forecast period. The growth may be attributed to the growth in the pharmaceutical industry further leading to the rise in the demand of the excipients for the formulation.

However, stringent regulatory guideline laid down by various regulatory bodies across the globe might hamper the growth of the market during the given time frame.

Major industry players profiled as part of the report are BASF SE, Avantor, Inc. and JRS Pharma GmbH & Co. KG among others.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Key Findings of the Study

4. Market Dynamics

5. Global Pharmaceutical Excipients Market Forecast by Excipient Type

5.1. Polymers

5.2. Alcohols

5.3. Sugars

5.4. Minerals

5.5. Others

6. Global Pharmaceutical Excipients Market Forecast by Formulation Type

6.1. Oral

6.2. Topical

6.3. Parenteral

6.4. Others

7. Global Pharmaceutical Excipients Market Forecast by Functionality

7.1. Coating Agents

7.2. Flavoring Agents & Sweeteners

7.3. Lubricants & Glidants

7.4. Colorants

7.5. Emulsifying Agents

7.6. Buffering Agents

7.7. Others

8. Global Pharmaceutical Excipients Market Forecast by Geography

9. Competitive intelligence

9.1. Market Share Analysis

9.2. Strategies of Key Players

9.3. Recent Investments and Deals

10. Company Profiles

10.1. Avantor Inc.

10.2. Signet Chemical Corporation Pvt. Ltd.

10.3. NB Entrepreneurs

10.4. JRS Pharma GmbH & Co. KG

10.5. Colorcon

10.6. Croda International PLC

10.7. ABF Ingredients

10.8. DFE Pharma

10.9. BASF SE

10.10. Fuji Chemical Industries Co. Ltd.

10.11. The Dow Chemical Company

For more information about this report visit https://www.researchandmarkets.com/research/9nmb67/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181220005920/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pharmaceutical Intermediates

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/20/2018 04:39 PM/DISC: 12/20/2018 04:39 PM

http://www.businesswire.com/news/home/20181220005920/en

AP RADIO
Update hourly